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As of May 16, 2020, it has been 68 days since 
the reporting of the first COVID-19 case in Turkey 
on March 11, 2020. During this period, the total 
number of confirmed cases reached 148,067, ac-
cording to figures reported by the Ministry of 
Health-Turkey. 
In our previous study, where we employed the 
SIR model to predict the progress of the COVID-19 
pandemic, it was emphasized how imperative it is to 
forecast the pandemic's progression in the coming fu-
ture to devise an appropriate policy response.1 Besides 
predicting the future progress of the pandemic, an 
equally maybe more critical policy question concerns 
the timing for easing and eventually lifting limitations 
such as curfews and closure of schools and businesses. 
As of now, since there is no preventive vaccine or pro-
phylactic drug for COVID-19, it is widely accepted 
that the transmission can only be reduced by isolation 
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ABS TRACT The instantaneous R in Turkey is estimated by Bayesian 
statistical inference that utilizes a 68-days-long dataset from the be-
ginning of the COVID-19 outbreak in Turkey for monitoring the pro-
gression of the pandemic. As it is also globally adapted, enforced 
social distancing measures help to keep the instantaneous reproduc-
tion number below one. The low levels of instantaneous R are referred 
to as a basis for several countries to relax their country-wide restric-
tions, while hindsight involves a possible second wave of infections 
to follow in China, Germany, and South Korea. Thus, policy and de-
cision-makers need to be vigilant regarding the pandemic's progress. 
It is not yet sure if it is possible to maintain the instantaneous repro-
duction number below one, especially at the lack of societal measures. 
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ÖZET Türkiye'deki anlık bulaştırma katsayısı COVID-19 salgınının 
başlangıcından itibaren 68 günlük bir veri seti kullanılarak Bayesyen 
istatistiksel çıkarım ile tahmin edilmiştir. Salgının kontrol altında tutu-
labilmesi için anlık bulaştırma katsayısının cari seviyesinin sürekli bir 
biçimde tahmin edilmesinin önemi vurgulanmıştır. Model çıktılarıyla 
anlık bulaştırma katsayısı tahminleri sunulmuştur. Zaman ilerledikçe 
elde edilen model çıktıları karşılaştırıldığında, sosyal mesafe önlemle-
rinin anlık bulaştırma katsayısının birin altında tutulması yönünde 
olumlu etkisi gözlemlenmektedir. Bununla birlikte, önlemlerin gevşe-
tilmesi sonrası Çin, Güney Kore ve Almanya gibi ülkelerde salgının 
ikinci dalgasının başlamış olabileceği de dikkate alındığında, anlık bu-
laştırma katsayısının kalıcı olarak birin altında tutulup tutulamayacağı 
belirsizliğini korumaktadır. Bu noktadan hareketle, politika yapıcılar 
ve karar vericilerin salgının sonraki aşamaları için tetikte olmaları ge-
rekmektedir. 
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and following strict hygiene rules.2 If the restrictions 
are relaxed and/or lifted prematurely, there might be 
a substantial risk of rebound. On the other hand, as 
long as such movement restrictions and social isola-
tion principles remain intact, economic hardship for 
millions of people is exacerbated. 
Estimating the instantaneous reproduction num-
ber may help us answer the second policy question 
regarding the timing for easing and eventually lifting 
limitations. The World Health Organization (WHO) 
suggests that the value for reproduction number 
should be equal to or less than 1.0 to alleviate the 
measures imposed by governments without further 
potential distress on their healthcare systems. When 
the effective reproduction number is larger than 1.0, 
the exponential growth of the outbreak poses distress 
risk to the healthcare system. 
There are variants of the reproduction number, 
such as the basic reproduction number, the effective 
reproduction number, the case reproduction number, 
and the instantaneous reproduction number. 
The instantaneous reproduction number, Rt, at 
time t can be estimated as in Equation (1).3 
 
                        (1) 
 
In equation (1), It stands for the number of new 
infections generated at time step t, whereas ws is the 
probability distribution of the infectivity profile 
which is dependent on time since infection of the 
case, s, but independent of calendar time, t. Hence, 
an individual will be most infectious at time s when 
ws is the largest. ws is typically related to individual 
biological factors such as symptom severity. 
Effective control measures undertaken at time t 
are expected to result in a sudden decrease in Rt, 
whereas the other reproduction number variants tend 
to respond rather slowly. Therefore, evaluating the 
efficiency of control measures is more effective when 
estimates of Rt are used.3 
Cori et al. developed a generic and robust tool, 
EpiEstim (implemented in Microsoft Excel and R), 
for estimating Rt. Assuming a gamma prior distribu-
tion for Rt, Bayesian statistical inference leads to an 
analytical expression for the posterior distribution of 
Rt. Since the resulting Rt estimates are usually not ro-
bust when the time step is small, they calculate esti-
mates over longer time windows, under the 
assumption that the instantaneous reproduction num-
ber is constant over that time window. At each time 
step t, they calculate the reproduction number over a 
time window of size τ ending at time t. These esti-
mates, denoted Rt,τ, yield the average transmissibility 
over the time window of length τ ending at time t. 
The posterior mean and standard deviation of Rt,τ are 
given in Equations (2) and (3), respectively.3 
           (2) 
 
                    (3) 
 
In Equations (2) and (3), a and b are the shape 
and scale parameters of the gamma prior distribution 
for Rt, respectively. 
In order to employ this method for the Turkish 
COVID-19 data, we need distribution parameters of 
the serial interval for COVID-19. Serial interval is 
defined as the time between onset of systems of a 
case and onset of symptoms of his/her secondary 
cases. We obtained the distribution parameters from 
literature.4 Hence, we assume a gamma distribution 
with shape parameter of 2.39 and rate parameter 0.48 
for serial interval, which correspond to a mean of 
4.98 days and a standard deviation of 3.22 days. Se-
rial interval distribution is depicted in Figure 1. 
Accordingly, the length of time steps, τ, is cho-
sen as 4 days since the method requires that τ should 
be less than the mean serial interval (4.98 days). 
The resulting Rt,4 estimates are depicted in  
Figure 2 and tabulated in Table 1. 
The median Rt,4 has declined to the critical 
threshold level of 1 on day 40 (April 18, 2020). Since 
then, it seemingly has plateaued and oscillated be-
tween 0.69 and 1.00. As of May 16, 2020, the me-
dian Rt,4 is estimated at 1.00 whereas the 95% 
credible interval is [0.98, 1.02].  
Although we observe that the lockdown meas-
ures have been quite effective in containing the 
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pandemic, it is still uncertain if the instantaneous 
reproduction number can be decisively kept under 
the critical threshold. It should also be noted that 
the second wave of the pandemic might have al-
ready started in countries such as China, South 
Korea, and Germany.5,6 Therefore, we suggest that 
policy and decision makers should be extremely 
vigilant before easing or lifting the precautionary 
measures. 
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FIGURE 1: Serial interval distribution for COVID-19 - Γ(2.39, 0.48).
FIGURE 2: Instantaneous R averaged over 4 days (posterior median and 95% credible interval).
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Time periods Posterior R moments  Main R Quantiles 
Start End Mean Std 0.025 quantile 0.05 quantile 0.25 quantile Median 0.75 quantile 0.95 quantile 0.975 quantile 
3 6 10.17 2.40 6.03 6.57 8.47 9.98 11.67 14.40 15.38 
4 7 14.50 2.11 10.65 11.20 13.02 14.39 15.86 18.14 18.93 
5 8 12.37 1.28 10.00 10.35 11.49 12.33 13.21 14.55 15.00 
6 9 10.45 0.77 9.00 9.22 9.92 10.43 10.96 11.74 12.01 
7 10 8.95 0.48 8.03 8.17 8.62 8.94 9.27 9.76 9.92 
8 11 8.12 0.33 7.50 7.59 7.90 8.12 8.34 8.66 8.77 
9 12 5.78 0.20 5.40 5.46 5.65 5.78 5.92 6.11 6.18 
10 13 4.07 0.13 3.82 3.86 3.98 4.07 4.15 4.28 4.32 
11 14 2.96 0.09 2.79 2.82 2.90 2.96 3.01 3.10 3.13 
12 15 2.19 0.06 2.07 2.09 2.15 2.19 2.24 2.30 2.32 
13 16 2.14 0.06 2.03 2.05 2.10 2.14 2.17 2.23 2.25 
14 17 2.86 0.06 2.75 2.76 2.82 2.86 2.90 2.96 2.97 
15 18 4.02 0.06 3.90 3.92 3.98 4.02 4.06 4.12 4.14 
16 19 3.90 0.05 3.80 3.82 3.87 3.90 3.94 3.99 4.01 
17 20 3.31 0.04 3.23 3.24 3.28 3.31 3.33 3.37 3.39 
18 21 2.51 0.03 2.45 2.46 2.49 2.51 2.53 2.56 2.57 
19 22 2.08 0.02 2.04 2.04 2.07 2.08 2.10 2.12 2.13 
20 23 1.79 0.02 1.75 1.76 1.78 1.79 1.81 1.83 1.83 
21 24 1.65 0.02 1.61 1.62 1.63 1.65 1.66 1.68 1.68 
22 25 1.64 0.02 1.61 1.61 1.63 1.64 1.65 1.67 1.67 
23 26 1.51 0.01 1.48 1.49 1.50 1.51 1.52 1.53 1.54 
24 27 1.49 0.01 1.46 1.47 1.48 1.49 1.50 1.51 1.52 
25 28 1.44 0.01 1.42 1.42 1.43 1.44 1.45 1.46 1.47 
26 29 1.45 0.01 1.42 1.43 1.44 1.45 1.45 1.47 1.47 
27 30 1.45 0.01 1.42 1.43 1.44 1.45 1.45 1.47 1.47 
28 31 1.42 0.01 1.40 1.40 1.41 1.42 1.43 1.44 1.44 
29 32 1.45 0.01 1.43 1.43 1.44 1.45 1.46 1.47 1.47 
30 33 1.44 0.01 1.42 1.42 1.43 1.44 1.45 1.46 1.46 
31 34 1.38 0.01 1.36 1.36 1.37 1.38 1.39 1.40 1.40 
32 35 1.28 0.01 1.26 1.27 1.28 1.28 1.29 1.30 1.30 
33 36 1.16 0.01 1.14 1.14 1.15 1.16 1.16 1.17 1.17 
34 37 1.05 0.01 1.04 1.04 1.05 1.05 1.06 1.06 1.07 
35 38 1.02 0.01 1.01 1.01 1.02 1.02 1.03 1.04 1.04 
36 39 1.03 0.01 1.01 1.01 1.02 1.03 1.03 1.04 1.04 
37 40 1.00 0.01 0.99 0.99 1.00 1.00 1.01 1.02 1.02 
38 41 0.98 0.01 0.97 0.97 0.98 0.98 0.99 0.99 1.00 
39 42 0.97 0.01 0.96 0.96 0.97 0.97 0.98 0.99 0.99 
40 43 0.99 0.01 0.98 0.98 0.99 0.99 1.00 1.00 1.01 
41 44 0.95 0.01 0.94 0.94 0.95 0.95 0.96 0.97 0.97 
42 45 0.91 0.01 0.89 0.90 0.90 0.91 0.91 0.92 0.92 
43 46 0.83 0.01 0.81 0.81 0.82 0.83 0.83 0.84 0.84 
44 47 0.74 0.01 0.73 0.73 0.73 0.74 0.74 0.75 0.75 
45 48 0.72 0.01 0.71 0.71 0.72 0.72 0.73 0.73 0.73 
46 49 0.70 0.01 0.68 0.68 0.69 0.70 0.70 0.71 0.71 
47 50 0.69 0.01 0.67 0.68 0.68 0.69 0.69 0.70 0.70 
48 51 0.74 0.01 0.72 0.73 0.73 0.74 0.74 0.75 0.75 
49 52 0.81 0.01 0.79 0.80 0.80 0.81 0.81 0.82 0.83 
50 53 0.86 0.01 0.84 0.85 0.85 0.86 0.87 0.87 0.88 
51 54 0.86 0.01 0.84 0.84 0.85 0.86 0.87 0.87 0.88 
52 55 0.77 0.01 0.76 0.76 0.77 0.77 0.78 0.79 0.79 
53 56 0.71 0.01 0.69 0.69 0.70 0.71 0.71 0.72 0.72 
54 57 0.71 0.01 0.69 0.69 0.70 0.71 0.71 0.72 0.72 
55 58 0.78 0.01 0.76 0.76 0.77 0.78 0.79 0.79 0.80 
56 59 0.86 0.01 0.84 0.84 0.85 0.86 0.87 0.88 0.88 
57 60 0.93 0.01 0.91 0.91 0.92 0.93 0.94 0.95 0.95 
58 61 0.92 0.01 0.90 0.90 0.91 0.92 0.93 0.94 0.94 
59 62 0.85 0.01 0.83 0.83 0.84 0.85 0.86 0.87 0.87 
60 63 0.76 0.01 0.74 0.74 0.75 0.76 0.77 0.78 0.78 
61 64 0.77 0.01 0.75 0.75 0.76 0.77 0.78 0.79 0.79 
62 65 0.82 0.01 0.80 0.80 0.81 0.82 0.83 0.84 0.84 
63 66 0.87 0.01 0.85 0.85 0.86 0.87 0.88 0.89 0.89 
64 67 0.99 0.01 0.97 0.97 0.98 0.99 1.00 1.01 1.01 
65 68 1.00 0.01 0.98 0.98 0.99 1.00 1.01 1.02 1.02
TABLE 1:  Estimates of the instantaneous reproduction number R.
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